Sept 30 (Reuters) – The weight-loss drug market is booming, with biotech firms racing to capture a slice of the fast-growing sector dominated by Novo Nordisk and Eli Lilly. Analysts expect the
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Subscribers: Please add the following to the Reuters Daybook for today, Wednesday, September 30: 12:30…
VIDEO SHOWS: HIGHLIGHTS OF THE MLB WILD CARD SERIES GAME BETWEEN THE BOSTON RED SOX…
Sept 30 (Reuters) - Theon International Plc: * THEON SECURES NEW ORDERS OF C.€50 MILLION…
MILWAUKEE, Sept 30 (Reuters) - US Trade Representative Jamieson Greer said on Wednesday that a…
By Jody Godoy Sept 30 (Reuters) - The Federal Trade Commission is conducting an industry-wide…
SAUDI ARABIA ESTIMATES FISCAL DEFICIT OF 3.6% OF GDP IN 2027 -STATEMENT (The article has…